Sclerosi Tuberosa - La Diagnosi Prenatale e le Nuove Terapie con gli inibitori di mTOR, 2014, https://youtu.be/TPyGb-iQyWMn
CURATOLO P., MOAVERO R., DE VRIES PJ., Neurological and neuropsychiatric aspects af tuberous sclerosis complex, 2015
KUMAR. V., ABBAS AK., FAUSTO N., ASTER JC., Le basi patologiche delle malattie degli organi e degli apparati, 8a ed. volume 2, Edra S.p.a, Milano, 2016
NORTHRUP H., KRUEGER D. A., Pediatric Neurology, 2013, 49: 243 e 254
RUPPE V., DILSIZ P., REISS CS., et al. Developmental brain abnormalities in tuberous sclerosis complex: a comparative tissue analysis of cortical tubers and peritubers cortex, Epilepsia, 2014, 55: 539-50
ZENG LH., XU. L., GUTMANN DH., WONG M., Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex, Ann Neurol, 2008, 63:444-53
CHUN-SHORE CJ., MAJOR P., MONTENEGRO M., THIELE E., Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Neurology, 2009, 72: 1165-69
NORTHRUP H., KRUEGER DA., On behalf of the International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr, Neurol 2013, 49: 243-54
NABBOUT R., SANTOS M., ROLLAND Y., DELALANDE O., DULAC O., CHIRON C. EARLY, Diagnosis of Subependimal giant cell astrocyroma in children with tuberous sclerosis., J Neurol Neurosurg Psychiatry 1999, 66: 370-75
SHARMA MC., RALTE AM., GAEKWAD S., SANTOSH V., SHANKAR SK., SANKAR C., Subependymal giant cell astrocytoma clinicopathological study of 23 cases with special emphasis on histogenesis, Pathol Oncol Res, 2004, 10: 219-24
CHUN-SHORE CJ., MAJOR P., THIELE E., CAMPOSANO S., MUZYKEWICZ D., The natural historyof the epilepsy in tuberous sclerosis complex. Epilepsia, 2010, 51:1236-41
CURATOLO P., NABBOUT R., JÒZWIAK S., On behalf of the participants of the TSC Consensus Meeting for SEGA and Epilepsy Management. Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations, Eur. J. Paediatr Neurol, 2012, 16: 582-86.
EDEN KE., DE VRIES PJ., MOSS J., RICHARDA C., OLIVER C., Self-injury and aggression in tuberous sclerosis complex: across syndrome comparison and associated risk markers, J. Neurodev Disord, 2014, 6: 10
LECLEZIO L., DE VRIES PJ., Advances in the treatment of tuberous sclerosis complex, Curr. Opin. Psychiatry 2015, 28: 113-20
DE VRIES PJ, PRATHER PA., The tuberous sclerosis complex. N. Engl. J. Med2007, 356: 92
DE VRIES PJ., GARDINER J., BOLTON PF., Neuropsychological attention deficits in tuberous sclerosis complex (TSC). AM j Med Genet A 2009, 149°: 387-95
TIERNEY KM., MCCARTNEY DL., SERFONTEIN JR, DE VRIES PJ., Neuropsychological attentuion skills and related behaviours in adults with tuberous sclerosis complex. Behav Genet, 2011, 41: 437-44
DE VRIES PJ., WHITTEMORE VH., LECLEZIO L., et al. Tuberous sclerosis complex associated neuropsychiatric disorders (TAND) and the TAND checklist, Pediatr Neurol, 2015, 52: 25-35
DARCY A. KRUEGER MD., PHD, MARGUERITE M. CARE, MD, KAREN AGRICOLA, FNP, CINDY TUDOR, PNP, MAXWELL MAYS, BS, AND DAVID NEAL FRANZ, MD, Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589289/
JONES EJH., DAWSON G., KELLY J., ESTES A., JANE WEBB S., Parent- delivered early intervention in infants at ri.sk for ASD: Effects on electrophysiological and habituation measures of social attention, https://www.ncbi.nlm.nih.gov/pubmed/28244271
